Open original FDA record ↗Recall record
- FDA identifier
- Z-1477-2011
- Company in FDA record
- Siemens Healthcare Diagnostics, Inc
- FDA classification date
- Mar 2, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Positive bias (40-55%) with patient results greater than the upper limit of normal and less than the upper limit of normal
Source facts
- Action
- Siemens Healthcare Diagnostics on 12 /14/10 issued Urgent Device Recall notice via Federal Express to accounts. This notice informs the customer of the recall and the actions that need to be taken. The Urgent Device Recall notice directs customers to immediately discontinue the use of ADVIA Centaur CA 125 II assay kits that contain CA 125 II reagent lot 144. It also recommends that patient results obtained with this reagent lot be reviewed. A confirmation fax-back form is included to ensure that all customers worldwide have been notified and have complied with the mandatory action. Technical questions, please contact the Technical Solutions Center at 1-877-229-3711
- Initiated
- 2010-12-14
- Root cause
- Process control
- Terminated
- 2013-04-12
- Distribution
- Worldwide distribution, including USA, Canada, Argentina, Austria, Belgium, China, Denmark, France, Germany, Great Britain, Greece, India, Italy, Japan, Korea, Lavitia, Lithuania, Malyasia, Mexico, Netherlands, Norway, Peru, Philippines, Poland, Portugal, Romania, Saudi Arabia, Switzerland, Serbia, Singapore, Slovakia, South Africa, Spain, Sweden, Czech Republic, Taiwan, Turkey, Uganda, and Venezuela
- Recall number
- Z-1477-2011
- Recall status
- Terminated
- CDRH record ID
- 96186
- FDA classified
- 2011-03-02
- Recall event number
- 57427